EUVIMEDEUVIMED entdecken
Open Access

Non‐Invasive Tumor Grade Evaluation in Von Hippel– Lindau‐Associated Clear Cell Renal Cell Carcinoma: A Magnetic Resonance Imaging‐Based Study

Aryan Zahergivar, Pouria Yazdian Anari, Neil Mendhiratta, Nathan Lay, Shiva Singh, Fatemeh Dehghani Firouzabadi, Aditi Chaurasia, Mahshid Golagha, Fatemeh Homayounieh, Rabindra Gautam, Stephanie Harmon, Evrim Turkbey und 6 weitere

Journal of Magnetic Resonance Imaging · 2024

DOI: 10.1002/jmri.29222 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Magnetic Resonance Imaging, 2024. Verfasst von Aryan Zahergivar und 17 weiteren Autor:innen. Beteiligte Einrichtung: Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Magnetic Resonance Imaging, Neoplasm Grading. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, NIH Clinical Center Research Award for Staff Clinicians (RASCL), National Institutes of Health, Intramural Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pathology grading is an essential step for the treatment and evaluation of the prognosis in patients with clear cell renal cell carcinoma (ccRCC).

Purpose

To investigate the utility of texture analysis in evaluating Fuhrman grades of renal tumors in patients with Von Hippel–Lindau (VHL)‐associated ccRCC, aiming to improve non‐invasive diagnosis and personalized treatment. Study Type Retrospective analysis of a prospectively maintained cohort. Population One hundred and thirty‐six patients, 84 (61%) males and 52 (39%) females with pathology‐proven ccRCC with a mean age of 52.8 ± 12.7 from 2010 to 2023. Field Strength and Sequences 1.5 and 3 T MRIs. Segmentations were performed on the T1 ‐weighted 3‐minute delayed sequence and then registered on pre‐contrast, T1 ‐weighted arterial and venous sequences. Assessment A total of 404 lesions, 345 low‐grade tumors, and 59 high‐grade tumors were segmented using ITK‐SNAP on a T1‐weighted 3‐minute delayed sequence of MRI. Radiomics features were extracted from pre‐contrast, T1‐weighted arterial, venous, and delayed post‐contrast sequences. Preprocessing techniques were employed to address class imbalances. Features were then rescaled to normalize the numeric values. We developed a stacked model combining random forest and XGBoost to assess tumor grades using radiomics signatures. Statistical Tests The model's performance was evaluated using positive predictive value (PPV), sensitivity, F1 score, area under the curve of receiver operating characteristic curve, and Matthews correlation coefficient. Using Monte Carlo technique, the average performance of 100 benchmarks of 85% train and 15% test was reported.

Results

The best model displayed an accuracy of 0.79. For low‐grade tumor detection, a sensitivity of 0.79, a PPV of 0.95, and an F1 score of 0.86 were obtained. For high‐grade tumor detection, a sensitivity of 0.78, PPV of 0.39, and F1 score of 0.52 were reported. Data Conclusion Radiomics analysis shows promise in classifying pathology grades non‐invasively for patients with VHL‐associated ccRCC, potentially leading to better diagnosis and personalized treatment. Level of Evidence 1 Technical Efficacy Stage 2

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsMagnetic Resonance ImagingNeoplasm GradingHumansFemaleMaleMiddle AgedRetrospective StudiesAdultAgedvon Hippel-Lindau DiseaseROC CurveImage Processing, Computer-AssistedPrognosis

Stichwörter der Autor:innen

clear cell renal cell carcinomafuhrman gradingmachine learningmagnetic resonance imagingradiomicsvon Hipple‐Lindau

Autor:innen und Institutionen

  • Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
  • Urology Oncology Branch, National Cancer Institutes, National Institutes of Health, Bethesda, Maryland, USA.
  • Artificial Intelligence Resource, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Pathology Department, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

ORCID-Profile: Ashkan A Malayeri

Förderung

  • Intramural NIH HHS
  • NIH Clinical Center Research Award for Staff Clinicians (RASCL)
  • National Institutes of Health, Intramural Research Program
  • National Institutes of Health

Zitieren

APA

Zahergivar, A., Yazdian Anari, P., Mendhiratta, N., Lay, N., Singh, S., Dehghani Firouzabadi, F., Chaurasia, A., Golagha, M., Homayounieh, F., Gautam, R., Harmon, S., Turkbey, E., Merino, M., Jones, E. C., Ball, M. W., Turkbey, B., Linehan, W. M., & Malayeri, A. A. (2024). Non‐Invasive Tumor Grade Evaluation in Von Hippel– Lindau‐Associated Clear Cell Renal Cell Carcinoma: A Magnetic Resonance Imaging‐Based Study. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.29222

Vancouver

Zahergivar A, Yazdian Anari P, Mendhiratta N, Lay N, Singh S, Dehghani Firouzabadi F, et al. Non‐Invasive Tumor Grade Evaluation in Von Hippel– Lindau‐Associated Clear Cell Renal Cell Carcinoma: A Magnetic Resonance Imaging‐Based Study. Journal of Magnetic Resonance Imaging. 2024. doi:10.1002/jmri.29222

BibTeX
@article{Zahergivar2024,
  author = {Zahergivar, Aryan and Yazdian Anari, Pouria and Mendhiratta, Neil and Lay, Nathan and Singh, Shiva and Dehghani Firouzabadi, Fatemeh and Chaurasia, Aditi and Golagha, Mahshid and Homayounieh, Fatemeh and Gautam, Rabindra and Harmon, Stephanie and Turkbey, Evrim and Merino, Maria and Jones, Elizabeth C and Ball, Mark W and Turkbey, Baris and Linehan, W Marston and Malayeri, Ashkan A},
  title = {Non‐Invasive Tumor Grade Evaluation in Von Hippel– Lindau‐Associated Clear Cell Renal Cell Carcinoma: A Magnetic Resonance Imaging‐Based Study},
  journal = {Journal of Magnetic Resonance Imaging},
  year = {2024},
  doi = {10.1002/jmri.29222}
}
Kostenlos starten →